Rigel Pharmaceuticals | RIGL - Market Capitalization


Rigel Pharmaceuticals reported $6.79B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 189.89B 13.64B Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 8.78B 236M Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Celldex Therapeutics USD 2.11B 307M Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Karyopharm Therapeutics USD 1.12B 989M Jul/2026
Ligand Pharmaceuticals USD 3.98B 241M Mar/2026
MacroGenics USD 287M 103M Jul/2026
Neurocrine Biosciences USD 13.25B 890M Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Ultragenyx Pharmaceutical USD 2.06B 159M Mar/2026
Veracyte USD 2.57B 758M Mar/2026